Søgning på udtrykket 'hepatitis' giver 101 resultater


Dokumenter [11] Sider [5] Kalender [44] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [11]

Version 8 er udarbejdet af en arbejdsgruppe nedsat af Dansk Selskab for Infektionsmedicin samt Dansk Selskab for Gastroenterologi og Hepatologi Medlemmer: Nina Weis (formand), Mette Rye Clausen, Peer Brehm Christensen, Henrik Krarup, Alex Lund Laursen, Lone Galmstrup Madsen

Diagnostik, behandling og forebyggelse af infektion med hepatitis A virus (HAV)

Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).

Anbefaling for profylakse og opfølgning af stikuheld og anden blodeksposition. Arbejdsgruppe: Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis

Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab

I forbindelse med Sundhedsstyrelsens udgivelse af "Personer med øget risiko ved COVID-19. Fagligt grundlag", har DSI beskrevet følgende specialespecifikke patienter med øget risiko for et alvorligt COVID-19 sygdomsforløb.

Sider [5]

…rede guidelines. Antiretroviral terapi: Henrik Nielsen, Jan Gerstoft, Jens Lundgren, Alex Laursen, Niels Obel, Olav Larsen, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smittede personer, Fertilitetsbehandling ved HIV og hepatitis B og C, HIV behandling af gravide, HIV post exposure profylakse (PEP), Pre-exposure profylakse mod HIV (PrEP), Borrelia: Anne-Mette Lebech, Sigurdur Skarphedinsson Borrelia klaringsrapport, COVID-19: Marie H…

…ioner: Dato for næste kursus Efterår 2024 (2 dage) : Sted Endnu ikke afklaret Delkursusledelse Jakob Bodilsen og Lars Omland Tidligere kurser 11. og 12. april 2018 9. og 10 september 2021 Gastroenterologiske infektioner og kronisk hepatitis: Dato for næste kursus Efterår 2023: Sted Hvidovre Hospital Delkursusledelse Lone Mygind, Micha Jepsen og Belinda Mössner Tidligere kurser 3. og 4. december 2020 HIV-infektion: Næste kursus 12. og 13. oktober 2022 (2 …

…ogiske oversigter (slides). www.natap.org/. National AIDS Treatment Advocacy Project ? en New York State non-profit NGO ledet af Jules Levin (som selv lever med Hiv og hepatitis). God side, hvis man mangler slides/figurer/tabeller fra studier præsenteret på senest afholdte konferencer kommer ofte med referat (inklusive Jules Levins fortolkning ud fra et patient/aktivist perspektiv). www.clinicaloptions.com/HIV.aspx. Et andet website for opdateringer og sammendrag af konferencer (slides).

Formål: Rejsefondens formål er at yde økonomisk støtte til lægelige medlemmer af DSI med henblik på deltagelse på følgende kongresser: NSCMID, ECCMID, IDWeek, HIV og Hepatitis Nordic Conference, EACS/Glasgow HIV og CROI.   Hvad kan der søges om?: Der kan søges om økonomisk støtte til registreringsafgift, rejseudgifter og indlogering til de respektive kongresser. Det er ikke et krav at man har et videnskabeligt bidrag på kongressen. Man kan højest få tildelt støtte til én kongres å…


Kalender [44]

28. juli, Globalt
17. juni, Auditorium 3+4, Hvidovre Hospital
10. maj, Auditorium 3+4, Hvidovre Hospital
28. oktober 2020, Paris, Frankrig
17. september 2020, Auditorium 3-4, Hvidovre Hospital
25. november 2019, Auditorium 3 og 4, Hvidovre Hospital
25. september 2019, London, England
11. september 2019, DGI-byen, København
22. maj 2019, Rom, Italien
10. maj 2019, Auditorium 3 og 4, Hvidovre Hospital
15. februar 2019, Auditorium, University of Southern Denmark, J. B. Winsløws Vej 25, Odense
24. januar 2019, Aarhus Universitetshospital
28. november 2018, Hvidovre Hospital
30. maj 2018, Rom, Italien
4. maj 2018, Hindsgavl, Middelfart
9. april 2018, Amsterdam, Holland
12. december 2017, Auditorium 3 og 4, Hvidovre Hospital
14. september 2017, IDA Mødecenter, Kalvebod Brygge 31, 1560 København V
30. maj 2017, Hvidovre Hospital
25. maj 2016, Rom, Italien
3. juni 2015, Barcelona, Spanien
24. marts 2015, Auditorium 3+4, Hvidovre Hospital
13. november 2014, Auditorium 3-4, Hvidovre Hospital
24. oktober 2014, Rigshospitalet
9. oktober 2014, Frankfurt, Tyskland
18. juli 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
23. maj 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
26. marts 2014, Barcelona, Spanien
30. juni 2013, Kuala Lumpur, Malaysia
20. marts 2013, Rom, Italien
25. oktober 2012, Danmarks Medie- og Journalisthøjskole
7. november 2011, Auditorium 93, Rigshospitalet
24. maj 2011, Rigshospitalet, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Current Opinion in Infectious Diseases
1.10.2022
Purpose of review . . Direct-acting antiviral (DAA) regimens targeting hepatitis C virus (HCV) are now approved for young children. This review examines recent DAA experience in children, current treatment recommendations and challenges, and potential treatment-as-prevention strategies. . Recent findings . . In 2021, the US FDA extended approval of two pan-genotypic DAA regimens, glecaprevir/pibrentasvir and sofosbuvir/velpatasvir, to children as young as age 3 years based on high success rates and …
Journal of Medical Virology
30.09.2022
Journal of Medical Virology, Accepted Article.
Journal of Medical Virology
28.09.2022
Journal of Medical Virology, Accepted Article.
PLoS One Infectious Diseases
27.09.2022
by Alice W. Lee, Wura Jacobs, Michelle Tran, Becky Nguyen, Dung N. Hua, John N. Ho, Thai Van Nguyen. Background Prevalence of hepatitis C virus (HCV) infection among Vietnamese Americans is reportedly high. Understanding the profile of those at greater risk of HCV in this ethnic population is a vital step to addressing this high prevalence. We hypothesize that certain sociodemographic characteristics increase the likelihood of having HCV in Vietnamese Americans. Methods Cross-sectional data from 2,497 Vie…
Clinical Infectious Diseases
22.09.2022
AbstractBackgroundHepatitis C virus (HCV) infection causes dysregulation and suppression of immune pathways involved in the control of tuberculosis (TB) infection. However, data on the role of chronic hepatitis C as a risk factor for active TB are lacking. We sought to evaluate the association between HCV infection and the development of active TB.MethodsWe conducted a cohort study in Georgia among adults tested for HCV antibodies (January 2015 – September 2o2o) and followed longitudinally for the develop…
BMJ Open
20.09.2022
. Objectives. Rural-to-urban migrant workers are susceptible to hepatitis B because of lack of self-protection awareness and social support. The aim of this study was to explore the factors influencing risk behaviours for hepatitis B among migrant workers based on the theory of planned behaviour (TPB). . Design. A cross-sectional survey. . Setting. Chongqing, China. . Participant. Migrant workers. . Primary and secondary outcome measures. The primary outcomes were the TPB variables. The second…
Journal of the American Medical Association
20.09.2022
This cohort study examines the validity of the Kidney Donor Profile Index’s hepatitis C virus (HCV) penalty during the direct-acting antiviral era by comparing 5-year allograft survival between recipients of kidneys from HCV-RNA–positive donors vs HCV-RNA–negative donors.
PLoS One Infectious Diseases
19.09.2022
by Pinggui Wang, Lijie Zhang, Jian He, Guomin Zhang, Yvan Ma, Weimin Lv, Xiaoshu Zhang, Jin An. . Hepatitis B is a major global public health threat. According to China’s National Notifiable Disease Reporting System (NNDRS), Gannan Tibetan Autonomous Prefecture (Gannan) had the highest incidence of hepatitis B in Gansu Province during 2004 to 2016. We evaluated NNDRS hepatitis B case reports from Gannan to determine accuracy of diagnosis and to understand factors associated with inaccuracy. We reviewed …
Clinical Microbiology and Infection
19.09.2022
to test a real-life sample pooling screening strategy that contributes to increase the diagnostic capacity of clinical laboratories and expand access to massive screening of hepatitis C.
Journal of Infectious Diseases
15.09.2022
AbstractBackground and AimsWe evaluated the patterns of peripheral TLR signalling activity and the expression of TLRs and NK cell activation in a cohort of patients experiencing severe hepatitis flares after stopping NA therapy.MethodsSamples were collected longitudinally from CHB patients enrolled in a prospective study of NA discontinuation. Patients experiencing hepatitis flares were compared to patients with normal ALT. PBMC were stimulated with TLR ligands and cytokine secretion in the cell culture sup…
BMC Infectious Diseases
15.09.2022
. Abstract. . Background. People who inject drugs (PWID) are disproportionally affected by hepatitis C virus (HCV) infection and many remain undiagnosed. HCV self-testing (HCVST) may be an effective approach to increase testing uptake, but has rarely been used among PWID. We assessed the usability and acceptability of HCVST among PWID in Kenya. . . Methods.…
International Journal of Infectious Diseases
15.09.2022
Hepatitis B virus (HBV) infection is considered one of the most critical public health problems worldwide, with an estimated 257 million people worldwide infected with HBV (www.who.int/hepatitis/publications/global-hepatitis-report2017/en/, 2017). More than 686,000 people die yearly from end-stage chronic hepatitis B (CHB) and CHB-related complications such as decompensated cirrhosis and hepatocellular carcinoma (www.who.int/mediacentre/factsheets/fs204/en/, 2017). Oral anti-viral drugs are r…
Lancet Infectious Diseases
14.09.2022
Hepatitis D virus (HDV) is a defective RNA virus requiring hepatitis B virus (HBV) to complete its lifecycle.1 HDV viruses have been classified into eight genotypes on the basis of their genome diversity, with specific geographical distribution. HDV genotype 1 (HDV-1) is distributed throughout Europe, the Middle East, the Americas, and north Africa, whereas HDV genotypes 2–8 occur regionally (eg, HDV-2 in Japan, Taiwan, and Russia; HDV-3 in South America; HDV-4 in Japan and Taiwan; and HDV-5 to HDV-8 in A…
Lancet Infectious Diseases
14.09.2022
Bulevirtide induced a significant decline in hepatitis D virus RNA over 24 weeks. After cessation of bulevirtide, hepatitis D virus RNA concentrations rebounded. Longer treatment durations and combination therapies should be investigated.
PLoS One Infectious Diseases
13.09.2022
by Meriem Kacem, Wafa Dhouib, Cyrine Bennasrallah, Imen Zemni, Hela Abroug, Manel Ben Fredj, Arwa Guedich, Leila Safer, Nissaf Ben Alaya, Maha Mastouri, Ines Bouanene, Asma Sriha Belguith. Background Healthcare workers (HCWs) are at high risk of hepatitis C virus (HCV) infection. Indeed, they are exposed to blood and body fluid which put them at an important risk of transmission of various blood borne pathogens including HCV. The goal of this study was to determine the magnitude of occupational exposure to…
Journal of the American Medical Association
13.09.2022
Only about one-third of US individuals with insurance who are diagnosed with hepatitis C receive timely treatment, according to a CDC Vital Signs report.
BMJ Open
8.09.2022
. Introduction. Globally, it is estimated that more than three-quarters of people with chronic hepatitis C virus (HCV) are unaware of their HCV status. HCV self-testing (HCVST) may improve access and uptake of HCV testing particularly among key populations such as people who inject drugs (PWID) and men who have sex with men (MSM) where HCV prevalence and incidence are high and barriers to accessing health services due to stigma and discrimination are common. . Methods and analysis. This randomised cont…
BMJ Open
8.09.2022
. Background. Autoimmune hepatitis (AIH) is a rare chronic progressive liver disease, managed with corticosteroids and immunosuppressants and monitored using a combination of liver biochemistry and histology. Liver biopsy (gold standard) is invasive, costly and has risk of complications. Non-invasive imaging using multiparametric magnetic resonance (mpMR) can detect the presence and extent of hepatic fibroinflammation in a risk-free manner. . Objective. To conduct early economic modelling to assess the…
International Journal of Infectious Diseases
8.09.2022
Hepatitis B virus (HBV) infection incurs a substantial burden worldwide due to the associated cost of prevention, diagnosis, and treatment (Zampino et al., 2015). Global HBV seroprevalence in 2016 was estimated to be 3.9%, with approximately 296 million people living with chronic HBV infection in 2019 and 1.5 million new infections annually (CDA Foundation Polaris Observatory, 2020; World Health Organization, 2021, 2017). In highly endemic countries, mother-to-child transmission (MTCT) accounts for most new…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Morbidity and Mortality Weekly Report (MMWR)
29.09.2022
This report describes a Hepatitis A Outbreak in the United States.
ProMED
16.09.2022
Hepatitis A -- New Zealand
Medscape Infectious Diseases
12.08.2022
Progress has occurred in reducing maternal-to-child transmission of hepatitis B, a leading cause of liver cancer, but is lagging, particularly in Africa. .
Morbidity and Mortality Weekly Report (MMWR)
11.08.2022
This report describes percentage of adults with current hepatitis C virus by health insurance coverage.
Morbidity and Mortality Weekly Report (MMWR)
9.08.2022
This report describes hepatitis C treatment among insured adults in the United States.
Eurosurveillance latest updates
4.08.2022
Following the report of an excess in paediatric cases of severe acute hepatitis of unknown aetiology by the United Kingdom (UK) on 5 April 2022, 427 cases were reported from 20 countries in the World Health Organization European Region to the European Surveillance System TESSy from 1 January 2022 to 16 June 2022. Here, we analysed demographic, epidemiological, clinical and microbiological data available in TESSy. Of the reported cases, 77.3% were 5 years or younger and 53.5% had a positive test for ad…
Morbidity and Mortality Weekly Report (MMWR)
28.07.2022
This report describes global progress towards the elimination of mother-to-child hepatitis B virus.
ProMED
20.07.2022
Hepatitis A -- United States
Medscape Infectious Diseases
13.07.2022
90% of children in two new studies tested positive for the virus, but there was no evidence of viral infection in liver biopsies. .
ProMED
11.07.2022
Hepatitis E -- Sudan
Medscape Infectious Diseases
6.07.2022
Data from an ongoing study in patients with compensated cirrhosis and clinically significant portal hypertension have raised hope for an emerging treatment option in this rare, deadly disease. .
Medscape Infectious Diseases
6.07.2022
“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.” .
Medscape Infectious Diseases
25.06.2022
Almost all children (90%) required hospitalization, 18 needed liver transplants, and 11 children have died. .

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● design: Christian Philip Fischer

Side indlæst på 0,516 s

Cookies og privatliv